In Vitro Antiviral Properties of Two Recombinant Sendai Virus Vectors Encoding ORFV 011 and ORFV 059 Genes
Viruses · 13.04.2026 · 18 (4) · 462
DOI: 10.3390/v18040462 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 13.04.2026. Verfasst von Álex Gómez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Patología Animal, Universidad de Zaragoza, 177 Calle de Miguel Servet, 50013 Zaragoza, Spain. Hauptthemen laut MEDLINE: Sendai virus, Genetic Vectors, Orf virus. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gobierno de Navarra.
Abstract (Originalsprache)
Orf virus (ORFV) is a globally distributed zoonotic parapoxvirus that causes a highly contagious mucocutaneous disease in small ruminants. Despite the urgent demand for vaccination-based control, no licensed vaccines are currently available universally. In this study, we generated two recombinant Sendai virus (SeV) vectors expressing ORFV 011 (rSeV-GFP-B2L) and ORFV 059 (rSeV-GFP-059) genes and evaluated their ability to stimulate antiviral responses in vitro. Following the transduction, we assessed transgene expression, innate immune activation, induction of interferon-stimulated genes (A3Z1, OBST2, SAMHD1), and antiviral activity. Both vectors significantly upregulated pattern recognition receptors (TLRs, RIG-I) and type I interferon (IFN-β) genes, with rSeV-GFP-059 inducing the strongest response. Remarkably, OBST2 was robustly upregulated, suggesting a potential role in restricting ORFV replication. Antiviral activity assays revealed a marked reduction in ORFV DNA copies and a mild decrease in ORFV RNA transcription in rSeV-GFP-059-transduced cells, particularly at later time points, accompanied by complete abrogation of the typical cytopathic effect. Collectively, these results demonstrate that SeV-based vectors, particularly rSeV-GFP-059, efficiently prime antiviral immunity and suppress ORFV replication, establishing a promising platform for further in vivo vaccine evaluation in sheep.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Patología Animal, Universidad de Zaragoza, 177 Calle de Miguel Servet, 50013 Zaragoza, Spain.
- Instituto Agroalimentario de Aragón-IA2, Universidad de Zaragoza, 177 Calle de Miguel Servet, 50013 Zaragoza, Spain.
- Instituto de Agrobiotecnología (CSIC-Gobierno de Navarra), 123 Avenida Pamplona, 31192 Mutilva, Spain.
- Instituto Navarro de Tecnologías e Infraestructuras Agroalimentarias (INTIA), 22 Avenida Serapio Huici, 31610 Villava/Atarrabia, Spain.
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA.
- Department of Immunology, Interfaculti Institute for Cell Biology, University Hospital Tübingen, 15 Auf d. Morgenstelle, 72076 Tübingen, Germany.
ORCID-Profile: Álex Gómez, Idoia Glaria, Irati Moncayola, Laura Arriazu, Ignacio de Blas, Benhur Lee, Lluís Luján, Ralf Amann, Ramsés Reina
Förderung
- Gobierno de Navarra
Zitieren
APA
Gómez, Á., Glaria, I., Moncayola, I., Puzol, L., Arriazu, L., Calero, A., de Blas, I., Nazábal, M., Hualde, I., Lee, B., Luján, L., Amann, R., Echeverría, I., & Reina, R. (2026). In Vitro Antiviral Properties of Two Recombinant Sendai Virus Vectors Encoding ORFV 011 and ORFV 059 Genes. Viruses, 18(4), 462. https://doi.org/10.3390/v18040462
Vancouver
Gómez Á, Glaria I, Moncayola I, Puzol L, Arriazu L, Calero A, et al. In Vitro Antiviral Properties of Two Recombinant Sendai Virus Vectors Encoding ORFV 011 and ORFV 059 Genes. Viruses. 2026;18(4):462. doi:10.3390/v18040462
BibTeX
@article{Gmez2026,
author = {Gómez, Álex and Glaria, Idoia and Moncayola, Irati and Puzol, Leonor and Arriazu, Laura and Calero, Ainhoa and de Blas, Ignacio and Nazábal, Mikel and Hualde, Itziar and Lee, Benhur and Luján, Lluís and Amann, Ralf and Echeverría, Irache and Reina, Ramsés},
title = {In Vitro Antiviral Properties of Two Recombinant Sendai Virus Vectors Encoding ORFV 011 and ORFV 059 Genes},
journal = {Viruses},
year = {2026},
volume = {18},
number = {4},
pages = {462},
doi = {10.3390/v18040462}
}
EUVIMED